Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Ave. D321, Boston, MA 02215, USA.
Support Care Cancer. 2012 Jan;20(1):195-8. doi: 10.1007/s00520-011-1269-7. Epub 2011 Sep 18.
As the number of cancer survivors continues to grow, identification of brief, valid psychological screening measures is critical for providing these survivors with appropriate psychosocial care. The distress thermometer (DT) is a one-item distress screening recommended by the National Comprehensive Cancer Network (NCCN) for screening cancer patients during their treatment.
In this study, the validity of the DT for identifying psychological distress in cancer survivors was evaluated by comparing results of the DT to the Brief Symptom Inventory-18 (BSI-18) in a sample of 120 survivors of adult onset cancer.
Results indicated that when using the NCCN suggested cutoff score of 5, the DT only identified 10 of the 21 BSI-18 positive cases of psychological distress (sensitivity 47.6%; specificity 90.9%). Using an alternative DT cutoff score of 4, 12 of the 21 BSI-18 positive cases were identified (sensitivity 51.7%; specificity 89.9%).
The results do not support the validity of the DT in survivors of adult cancers.
随着癌症幸存者人数的不断增加，确定简短、有效的心理筛查措施对于为这些幸存者提供适当的社会心理护理至关重要。痛苦温度计（DT）是国家综合癌症网络（NCCN）推荐的一种用于在癌症患者治疗期间进行筛查的单项目痛苦筛查工具。
在这项研究中，通过将 DT 的结果与 120 名成年癌症幸存者的简明症状量表-18 （BSI-18）进行比较，评估了 DT 用于识别癌症幸存者心理困扰的有效性。
结果表明，当使用 NCCN 建议的 5 分截断值时，DT 仅识别出 21 例 BSI-18 阳性心理困扰病例中的 10 例（灵敏度 47.6%；特异性 90.9%）。使用替代的 DT 截断值 4 分，可识别出 21 例 BSI-18 阳性病例中的 12 例（灵敏度 51.7%；特异性 89.9%）。
结果不支持 DT 在成年癌症幸存者中的有效性。
